{"id":"https://openalex.org/W1992103497","doi":"https://doi.org/10.2500/aap.2008.29.3160","title":"Efficacy of omalizumab in the treatment of atopic dermatitis: A pilot study","display_name":"Efficacy of omalizumab in the treatment of atopic dermatitis: A pilot study","alternate_titles":[],"publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W1992103497","doi":"https://doi.org/10.2500/aap.2008.29.3160","mag":"1992103497","pmid":"https://pubmed.ncbi.nlm.nih.gov/18926061"},"language":"en","primary_location":{"id":"doi:10.2500/aap.2008.29.3160","doi":"https://doi.org/10.2500/aap.2008.29.3160","is_oa":false,"landing_page_url":"https://doi.org/10.2500/aap.2008.29.3160","pdf_url":null,"source":{"id":"https://openalex.org/S49250914","display_name":"Allergy and Asthma Proceedings","issn_l":"1088-5412","issn":["1088-5412","1539-6304"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320401","host_organization_name":"OceanSide Publications, Inc","host_organization_lineage":["https://openalex.org/P4310320401"],"host_organization_lineage_names":["OceanSide Publications, Inc"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and Asthma Proceedings","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1992103497"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018079978","display_name":"Lee E. Sheinkopf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210156876","display_name":"VA Greater Los Angeles Healthcare System","ror":"https://ror.org/05xcarb80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210138663","https://openalex.org/I4210156876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lee E. Sheinkopf","raw_affiliation_strings":["From the VA Greater Los Angeles Healthcare System/University of California, Los Angeles, Department of Allergy and Immunology, Los Angeles, California, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the VA Greater Los Angeles Healthcare System/University of California, Los Angeles, Department of Allergy and Immunology, Los Angeles, California, and","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210156876"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079918052","display_name":"Asif Rafi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Asif W. Rafi","raw_affiliation_strings":["Allergy Asthma Care Center, Inc., 11500 West Olympic Boulevard., Suite 630, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy Asthma Care Center, Inc., 11500 West Olympic Boulevard., Suite 630, Los Angeles, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072134926","display_name":"LanAnh T. Do","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"LanAnh T. Do","raw_affiliation_strings":["Allergy Asthma Care Center, Inc., 11500 West Olympic Boulevard., Suite 630, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy Asthma Care Center, Inc., 11500 West Olympic Boulevard., Suite 630, Los Angeles, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039382729","display_name":"Roger M. Katz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roger M. Katz","raw_affiliation_strings":["Allergy Asthma Care Center, Inc., 11500 West Olympic Boulevard., Suite 630, Los Angeles, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allergy Asthma Care Center, Inc., 11500 West Olympic Boulevard., Suite 630, Los Angeles, California","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089628092","display_name":"William B. Klaustermeyer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I4210156876","display_name":"VA Greater Los Angeles Healthcare System","ror":"https://ror.org/05xcarb80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210138663","https://openalex.org/I4210156876"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William B. Klaustermeyer","raw_affiliation_strings":["From the VA Greater Los Angeles Healthcare System/University of California, Los Angeles, Department of Allergy and Immunology, Los Angeles, California, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the VA Greater Los Angeles Healthcare System/University of California, Los Angeles, Department of Allergy and Immunology, Los Angeles, California, and","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I4210156876"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.6787,"has_fulltext":false,"cited_by_count":160,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98987326,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"29","issue":"5","first_page":"530","last_page":"537"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":1.0},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":1.0},{"id":"https://openalex.org/keywords/allergic-asthma","display_name":"allergic asthma","score":0.968999981880188},{"id":"https://openalex.org/keywords/serum-ige","display_name":"serum IgE","score":0.8169999718666077},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/disease-severity","display_name":"disease severity","score":0.6370000243186951},{"id":"https://openalex.org/keywords/investigator-s-global-assessment","display_name":"Investigator's Global Assessment","score":0.7559999823570251},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.9818137288093567},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9741931557655334},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.8826618790626526},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.8058944344520569},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.7327356934547424},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4993715286254883},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38599514961242676},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2375025451183319},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1379089057445526}],"mesh":[{"descriptor_ui":"D000069444","descriptor_name":"Omalizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000888","descriptor_name":"Antibodies, Anti-Idiotypic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007073","descriptor_name":"Immunoglobulin E","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2500/aap.2008.29.3160","doi":"https://doi.org/10.2500/aap.2008.29.3160","is_oa":false,"landing_page_url":"https://doi.org/10.2500/aap.2008.29.3160","pdf_url":null,"source":{"id":"https://openalex.org/S49250914","display_name":"Allergy and Asthma Proceedings","issn_l":"1088-5412","issn":["1088-5412","1539-6304"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320401","host_organization_name":"OceanSide Publications, Inc","host_organization_lineage":["https://openalex.org/P4310320401"],"host_organization_lineage_names":["OceanSide Publications, Inc"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and Asthma Proceedings","raw_type":"journal-article"},{"id":"pmid:18926061","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18926061","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Allergy and asthma proceedings","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2021236140","https://openalex.org/W2037588384","https://openalex.org/W3193558166","https://openalex.org/W1974217538","https://openalex.org/W7100848944","https://openalex.org/W1969305219","https://openalex.org/W1597018795","https://openalex.org/W2337282405","https://openalex.org/W2085050514","https://openalex.org/W136702448"],"abstract_inverted_index":{"Omalizumab":[0],"is":[1,156],"a":[2,20,46],"unique":[3],"biologic":[4],"therapeutic":[5],"drug":[6],"approved":[7],"for":[8,39],"treating":[9,159],"atopic":[10,43,146],"patients":[11,64,114,137,162],"with":[12,19,48,65,163],"moderate":[13,66,164],"to":[14,26,33,56,67,126,165],"severe":[15,68,166],"persistent":[16,69,167],"allergic":[17,70,168],"asthma":[18,71],"serum":[21],"IgE":[22,83,87,92,121,130],"ranging":[23],"from":[24,124],"30":[25],"700":[27],"IU/mL.":[28],"This":[29],"study":[30,152],"was":[31,54,97,132],"performed":[32,55],"examine":[34],"the":[35,40,58,78],"efficacy":[36,59],"of":[37,42,60,144],"omalizumab":[38,61,155],"treatment":[41],"dermatitis":[44,147],"(AD),":[45],"disease":[47],"significant":[49,142],"morbidity.":[50],"A":[51],"prospective":[52],"analysis":[53],"assess":[57],"in":[62,158,161],"21":[63,136],"and":[72,90,104,140],"AD.":[73],"Patients":[74],"were":[75,118],"stratified":[76],"into":[77],"following":[79],"groups:":[80],"very":[81],"high":[82,86],"(>700":[84],"IU/mL),":[85,89],"(186-700":[88],"normal":[91],"(0-185":[93],"IU/mL).":[94,134],"AD":[95,160],"severity":[96],"assessed":[98],"at":[99],"0,":[100],"1,":[101],"3,":[102],"6,":[103],"9":[105],"months":[106],"via":[107],"an":[108],"Investigator":[109],"Global":[110],"Assessment":[111],"index.":[112],"Twenty-one":[113],"(14-64":[115],"years":[116],"old)":[117],"evaluated.":[119],"Pretreatment":[120],"levels":[122],"ranged":[123],"18.2":[125],"8396":[127],"IU/mL,":[128],"(mean":[129],"level":[131],"1521":[133],"All":[135],"showed":[138],"clinical":[139],"statistically":[141],"improvement":[143],"their":[145],"(p<0.00052).":[148],"In":[149],"conclusion,":[150],"this":[151],"indicates":[153],"that":[154],"effective":[157],"asthma.":[169]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1992103497","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":19}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
